Nuclear Medicine: Page 13

SNMMI highlights prostate cancer study

By AuntMinnie.com staff writers

A recent study highlighted by the Society for Nuclear Medicine and Molecular Imaging (SNMMI) presents a new PET scoring system for predicting whether prostate cancer patients will respond to treatment with lutetium-177 prostate-specific membrane antigen-617.

April 20, 2023

Ionetix produces first At-211 radioisotope at new facility

By AuntMinnie.com staff writers

Cyclotron technology developer Ionetix has produced the first batch of therapeutic radioisotope astatine-211 (At-211) at its new alpha isotope manufacturing facility in Lansing, MI.

April 18, 2023

Racial disparities persist in genitourinary clinical trials

By Will Morton

Racial disparities persist in genitourinary clinical trials of new biologic drugs and PET imaging radiotracers, according to a study published April 13 in Current Problems in Cancer.

April 16, 2023

AI may help diagnose cardiac amyloidosis on whole-body scintigraphy

By Will Morton

An artificial intelligence (AI) model trained on whole-body scintigraphy images may be able to identify patients at risk of cardiac amyloidosis, according to a study published April 12 in JACC: Cardiovascular Imaging.

April 16, 2023

Ultrasound noninferior to scintigraphy in surgical thyroid imaging

By Amerigo Allegretto

Ultrasound may be a viable alternative to scintigraphy for pre-surgical imaging of patients with primary hyperparathyroidism, even without the addition of contrast media, suggest findings published April 13 in JAMA Otolaryngology.

April 13, 2023

FDA clears Fusion's targeted alpha therapy

By AuntMinnie.com staff writers

Fusion Pharmaceuticals has secured clearance from the U.S. Food and Drug Administration (FDA) for its radiopharmaceuticals actinium-225-FPI-2068 and corresponding imaging analog Indium-111-FPI-2107.

April 12, 2023

ImaginAB licenses immuno-PET tracer to Leucid

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAB has licensed its zirconium-89 crefmirlimab berdoxam radiotracer to biotech company Leucid for use in studies of solid tumors.

April 11, 2023

China authorizes Qi Kang Medical Technology to open new facility

By AuntMinnie.com staff writers

The Department of Ecology and Environment of Jiangsu Province in China has authorized Eckert & Ziegler subsidiary Qi Kang Medical Technology to construct a radioisotope production facility in Jintan.

April 11, 2023

PET/CT bests bone scintigraphy for detecting invasive breast cancer

By Will Morton

PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.

April 11, 2023

SPECT/CT helps assess patients with knee pain following arthroplasty

By Will Morton

SPECT/CT imaging is an effective way to evaluate noninfected painful knees in patients after they have undergone knee arthroplasty, a literature review published March 21 in the Journal of Orthopaedic Surgery and Research has found.

April 2, 2023

Ablaze secures peptide drug license from RayzeBio

By AuntMinnie.com staff writers

Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. Ablaze plans to market the new drug in China, where the company is headquartered.

March 30, 2023

On Target Laboratories touts Cytalux study results

By AuntMinnie.com staff writers

Molecular imaging agent developer On Target Laboratories is highlighting clinical results from a phase III study of its Cytalux injection for intraoperative imaging of lung cancer.

March 26, 2023

Previous Page

Page 13 of 438

Next Page